Cancer/testis antigens: an expanding family of targets for cancer immunotherapy - PubMed (original) (raw)
Review
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
Matthew J Scanlan et al. Immunol Rev. 2002 Oct.
Abstract
Cancer/testis (CT) antigens are a category of tumor antigens with normal expression restricted to male germ cells in the testis but not in adult somatic tissues. In some cases, CT antigens are also expressed in ovary and in trophoblast. In malignancy, this gene regulation is disrupted, resulting in CT antigen expression in a proportion of tumors of various types. Since their initial identification by T-cell epitope cloning, the list of CT antigens has been greatly expanded through serological expression cloning (SEREX) and differential mRNA expression analysis, and approximately 20 CT antigens or antigen families have been identified to date. Characteristics commonly shared by CT antigens, aside from the highly tissue-restricted expression profile, include existence as multigene families, frequent mapping to chromosome X, heterogeneous protein expression in cancer, likely correlation with tumor progression, induction of expression by hypomethylation and/or histone acetylation, and immunogenicity in cancer patients. Spontaneous humoral and cell-mediated immune responses have been demonstrated against several CT antigens, including NY-ESO-1, MAGE-A, and SSX antigens. Since CT antigens are immunogenic and highly restricted to tumors, their discovery has led directly to the development of antigen-specific cancer vaccines, and clinical trials with MAGE-A and NY-ESO-1 are in progress.
Similar articles
- Cancer/testis (CT) antigens: potential targets for immunotherapy.
Caballero OL, Chen YT. Caballero OL, et al. Cancer Sci. 2009 Nov;100(11):2014-21. doi: 10.1111/j.1349-7006.2009.01303.x. Epub 2009 Aug 1. Cancer Sci. 2009. PMID: 19719775 Free PMC article. Review. - NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R, Al-Khadairi G, Roelands J, Hendrickx W, Dermime S, Bedognetti D, Decock J. Thomas R, et al. Front Immunol. 2018 May 1;9:947. doi: 10.3389/fimmu.2018.00947. eCollection 2018. Front Immunol. 2018. PMID: 29770138 Free PMC article. Review. - [Targeting cancer antigen (MAGE-A4, NY-ESO -1) for immunotherapy].
Imai N, Ikeda H, Shiku H. Imai N, et al. Nihon Rinsho. 2012 Dec;70(12):2125-9. Nihon Rinsho. 2012. PMID: 23259384 Review. Japanese. - Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
Bodey B. Bodey B. Expert Opin Biol Ther. 2002 Aug;2(6):577-84. doi: 10.1517/14712598.2.6.577. Expert Opin Biol Ther. 2002. PMID: 12171503 Review. - Immunomic analysis of human sarcoma.
Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ, Scanlan MJ. Lee SY, et al. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2651-6. doi: 10.1073/pnas.0437972100. Epub 2003 Feb 24. Proc Natl Acad Sci U S A. 2003. PMID: 12601173 Free PMC article.
Cited by
- Genomic analysis of human brain metastases treated with stereotactic radiosurgery reveals unique signature based on treatment failure.
Shireman JM, White Q, Ni Z, Mohanty C, Cai Y, Zhao L, Agrawal N, Gonugunta N, Wang X, Mccarthy L, Kasulabada V, Pattnaik A, Ahmed AU, Miller J, Kulwin C, Cohen-Gadol A, Payner T, Lin CT, Savage JJ, Lane B, Shiue K, Kamer A, Shah M, Iyer G, Watson G, Kendziorski C, Dey M. Shireman JM, et al. iScience. 2024 Mar 27;27(4):109601. doi: 10.1016/j.isci.2024.109601. eCollection 2024 Apr 19. iScience. 2024. PMID: 38623341 Free PMC article. - Humoral immunoprofiling identifies novel biomarkers and an immune suppressive autoantibody phenotype at the site of disease in pancreatic ductal adenocarcinoma.
Maimela PWM, Smith M, Nel AJM, Bernam SDP, Jonas EG, Blackburn JM. Maimela PWM, et al. Front Oncol. 2024 Feb 21;14:1330419. doi: 10.3389/fonc.2024.1330419. eCollection 2024. Front Oncol. 2024. PMID: 38450186 Free PMC article. - Structural basis for RAD18 regulation by MAGEA4 and its implications for RING ubiquitin ligase binding by MAGE family proteins.
Griffith-Jones S, Álvarez L, Mukhopadhyay U, Gharbi S, Rettel M, Adams M, Hennig J, Bhogaraju S. Griffith-Jones S, et al. EMBO J. 2024 Apr;43(7):1273-1300. doi: 10.1038/s44318-024-00058-9. Epub 2024 Mar 6. EMBO J. 2024. PMID: 38448672 Free PMC article. - Designing, cloning and simulation studies of cancer/testis antigens based multi-epitope vaccine candidates against cutaneous melanoma: An immunoinformatics approach.
Khalid S, Guo J, Muhammad SA, Bai B. Khalid S, et al. Biochem Biophys Rep. 2024 Jan 25;37:101651. doi: 10.1016/j.bbrep.2024.101651. eCollection 2024 Mar. Biochem Biophys Rep. 2024. PMID: 38371523 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources